| ATCC 29098| Desulfomonas pigra| Desulfomonas pigra Moore et al. 1976| Desulfovibrio piger| Desulfovibrio piger (Moore et al. 1976) Loubinoux et al. 2002| DSM 749
Gut Microbiota: Desulfovibrio piger is found in the human gastrointestinal tract, and its presence is often associated with the gut microbiota. The gut microbiota plays a crucial role in digestion, nutrient absorption, and overall gut health.
Sulfate Reduction: Desulfovibrio bacteria, including Desulfovibrio piger, are sulfate-reducing bacteria. They can metabolize sulfate to produce hydrogen sulfide. While low levels of hydrogen sulfide may have signaling and regulatory roles in the gut, excessive production can be associated with negative health effects.
Hydrogen Sulfide Production: Hydrogen sulfide is known to have both beneficial and potentially harmful effects. In low concentrations, it may have signaling functions and contribute to maintaining gut homeostasis. However, higher concentrations of hydrogen sulfide can be toxic and are associated with inflammation and other health issues.
Implications for Gut Health: Some studies have suggested a potential link between Desulfovibrio species and certain gut conditions, including inflammatory bowel diseases (IBD) such as Crohn's disease. However, the relationship between Desulfovibrio piger and health outcomes is complex, and further research is needed to understand the mechanisms involved.
Dietary Influence: Dietary factors, such as the intake of sulfur-containing compounds, can influence the abundance and activity of sulfate-reducing bacteria, including Desulfovibrio species, in the gut.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 2.52 | 0 | 0 | 5 | 29496 | 0 | 18090 | 5751.2 | 3900 | 6295.3 | 0 | 13674 | 0 %ile | 100 %ile |
biomesight | 21.21 | 0 | 10 | 10 | 10350 | 0 | 8592 | 1716.5 | 335 | 3508 | 0 | 3000 | 0 %ile | 97.4 %ile |
thorne | 96.55 | 5 | 3880 | 0 | 3173 | 617.3 | 42 | 1303.9 | 5 | 143 | 0 %ile | 100 %ile | ||
thryve | 24.19 | 0 | 15 | 1 | 29916 | 0 | 11377 | 2575.9 | 96 | 4490.5 | 0 | 7474 | 0 %ile | 100 %ile |
ubiome | 15.59 | 0 | 58 | 20 | 64038 | 0 | 31848 | 12219.1 | 10277 | 10014.9 | 1845 | 21083 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
XenoGene | 0 | 100 | 0 | 0.01 |
Microba Co-Biome | 0 | 2270 | 0 | 0.227 |
Thorne (20/80%ile) | 13.59 | 75.35 | 0.0014 | 0.0075 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 22.882 % | 0.157 % | 0.328 % | 678.0 | 2963 |
CerbaLab | 100 % | 0.026 % | 0.028 % | 3.0 | 3 |
CosmosId | 12.5 % | 0.278 % | 0.113 % | 4.0 | 32 |
custom | 32.787 % | 0.981 % | 0.904 % | 20.0 | 61 |
es-xenogene | 65.517 % | 0.073 % | 0.145 % | 19.0 | 29 |
GanzimmunDiag | 100 % | 0.794 % | 0 % | 3.0 | 3 |
Medivere | 85.714 % | 0.571 % | 0.589 % | 6.0 | 7 |
Microba | 28.571 % | 0.196 % | 0.185 % | 8.0 | 28 |
SequentiaBiotech | 52.778 % | 0.96 % | 0.57 % | 19.0 | 36 |
Thorne | 78.846 % | 0.025 % | 0.081 % | 82.0 | 104 |
Thryve | 22.302 % | 0.235 % | 0.428 % | 310.0 | 1390 |
uBiome | 15.53 % | 1.222 % | 1.001 % | 123.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.